Editorial review illustration for Sesame — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Is Sesame Legit? Credentialing and the Compounding Pathway

Asking whether Sesame is legit is really about verification. This independent review defines legitimacy for a telehealth GLP-1 program, the licensure and credentialing worth confirming, how the 503A compounding pathway works, the red flags to watch, and the genetic layer credentialing checks never reach.

Editorial review illustration for Fridays — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Fridays Pricing: GLP-1 Cost and Access Models Explained

Fridays Pricing represents a subscription-based model for GLP-1 access, but understanding how treatment costs are structured requires evaluating compounded versus branded options, pharmacy credentials, and individual clinical factors that influence eligibility and dosing.

Editorial review illustration for Agile Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Agile Telehealth GLP-1: Evaluating Remote Prescribing and Genetic Context

Agile Telehealth GLP-1 represents a shift toward remote medication access for weight management and metabolic health. Understanding how telehealth prescribing works alongside genetic predispositions and clinical markers helps patients make informed decisions about suitability and medication choice.

Editorial review illustration for LifeMD — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

LifeMD Pricing: Subscription Tiers and What Is Included

How LifeMD pricing works as a subscription: the recurring membership fee, what each tier bundles, the medication cost that sits outside it, and the renewal terms worth reading first. Independent editorial review, current as of April 2026, plus the genetic baseline no tier includes.

Editorial review illustration for Felix Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Felix Health Cost: Biomarker-Guided Pricing and Personalized Access

Felix Health charges $149-$289/mo for GLP-1 treatment. PlexusDx offers compounded semaglutide and tirzepatide at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed pharmacies. Genetic predispositions and biomarker context may inform cost-effectiveness and treatment alignment with individual health profiles.

Editorial review illustration for AgelessRx — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Agelessrx Pricing: Understanding Compounded GLP-1 Cost and Clinical Value

Agelessrx offers compounded semaglutide and tirzepatide at various price points. Understanding pricing models, what's included in each tier, and how genetic predispositions affect medication suitability can help patients make informed decisions about GLP-1 therapy cost and clinical fit.

Editorial review illustration for Orderly Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Orderly Meds Pricing: Understanding Compounded GLP-1 Subscription Models

Orderly Meds pricing varies by medication and subscription tier.

Editorial review illustration for Henry Meds — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Henry Meds Pricing Explained: Program Fees and Medication Cost

Henry Meds prices its GLP-1 program per medication and advertises its lowest twelve-month prepaid rate, so the monthly figure you actually pay is higher. This independent review breaks down the pricing ladder, what each plan bundles, the cancellation terms, and the genetic context PlexusDx layers on before any protocol begins.

Editorial review illustration for Ivim Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Ivim Health Pricing: How the Telehealth GLP-1 Bill Is Built

This independent editorial breaks down how Ivim Health prices its GLP-1 telehealth program — the membership fee, medication cost, dispensing pathway, and billing cadence that drive the monthly total — and contrasts it with published PlexusDx protocol pricing and upstream genetic context.

Editorial review illustration for Curai Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Curai Health Cost: Comparing GLP-1 Pricing Models and Clinical Value

Curai Health offers telehealth-based GLP-1 prescription services with program and medication fees. Understanding their pricing structure helps patients evaluate total cost of care and compare with compounded pharmacy options tailored to individual clinical profiles.

Editorial review illustration for 9amHealth — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

9Amhealth Cost: Understanding GLP-1 Pricing and Personalization Strategies

9Amhealth pricing varies by program tier and medication type. Understanding total costs—including consultations, labs, and ongoing prescriptions—helps patients evaluate GLP-1 options.

Editorial review illustration for Brello — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Brello Pricing: What You Actually Pay for GLP-1 Treatment

Brello pricing includes medication costs, provider consultation fees, and program membership. Understanding the complete cost structure helps patients evaluate GLP-1 treatment affordability against other options, including compounded alternatives with transparent pricing models.

Editorial review illustration for Fella Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Fella Health Review: The Business Model, Examined

This independent Fella Health review examines the business model behind men-focused GLP-1 telehealth: subscription logic, the prescribing-to-fulfillment chain, and the real trade-offs of the design. It closes with the metabolic pathway context that no service-level review can capture on its own.

Editorial review illustration for Strut Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Strut Health Review: Compounding Pharmacy Standards and Personalization

Strut Health offers compounded GLP-1 medications through licensed pharmacies. This review evaluates compounding standards, licensure requirements, and how genetic insights can inform more personalized treatment selection beyond generic protocols.

Editorial review illustration for Direct Meds — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Direct Meds Pricing: Cost Structure and What Drives It

A breakdown of how Direct Meds prices its GLP-1 program, including the subscription structure and what drives the monthly total. It explains the cash-pay and branded-versus-compounded split, references the April 2026 telehealth market range, and describes the one cost input no quote includes: your baseline genetics.

Editorial review illustration for Agile Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Agile Health Reviews: Licensure, Compounding, and Oversight

An independent editorial review of Agile Health that starts from the criteria that actually matter for trust: state-licensed clinicians, the 503A compounding pathway, real clinical oversight, and pricing transparency. It also covers the pathway-level genetic context that no telehealth review score can capture before you commit.

Editorial review illustration for Felix Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Felix Health Review: Clinical Evaluation for GLP-1 Access

Felix Health operates a telehealth model for GLP-1 prescriptions with flat monthly pricing. This review evaluates their business structure, clinical oversight, and how their approach compares to compounded GLP-1 options available through licensed 503A pharmacies.

Editorial review illustration for TRT Nation — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

TRT Nation Review: Clinical Safety Profile and GLP-1 Compounding Standards

TRT Nation Review is a testosterone replacement therapy platform that has expanded into GLP-1 compounded peptide offerings.

Editorial review illustration for Orderly Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Orderly Meds Reviews: Compounded GLP-1 Pharmacy Safety Check

Orderly Meds Reviews is a comparison platform for compounded GLP-1 providers. This guide explains how to assess pharmacy quality, verify licensing, and understand the clinical differences between reputable compounding services and cost-cutting alternatives.

Editorial review illustration for Noom and WeightWatchers — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Noom vs Weightwatchers: Which Approach Complements Medication-Supported Weight Management

Noom and Weightwatchers offer distinct behavioral frameworks for weight management—psychology-first vs. point-based systems—but neither replaces medical evaluation or medication therapy.

Editorial review illustration for Mochi Health — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Mochi Review: Clinical Assessment of Telehealth GLP-1 Delivery

Mochi is a telehealth platform offering GLP-1 medications through remote consultations. This review evaluates Mochi's clinical approach, cost structure, and how precision-based alternatives like compounded GLP-1 with genetic assessment may support more individualized treatment planning.

Editorial review illustration for LifeMD — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

LifeMD Review: Telehealth GLP-1 Access and Clinical Fit

LifeMD is a telehealth platform offering remote GLP-1 prescription services for weight loss and diabetes management. This review examines LifeMD's model, costs, clinical oversight, and how it compares to compounded GLP-1 providers like PlexusDx.

Editorial review illustration for Hers — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Hers Review: Clinical Assessment of Telehealth GLP-1 Access

Hers is a telehealth platform offering prescription GLP-1 medications for weight management through remote consultations. This review examines Hers' clinical model, costs, eligibility criteria, and how precision-based approaches like genetic assessment may complement telehealth evaluation.

Editorial review illustration for GoodLife — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

GoodLife Meds Review: Safety, Sourcing, and What to Know

GoodLife Meds Review is a telehealth GLP-1 provider offering compounded semaglutide and tirzepatide.

Editorial review illustration for Fridays — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Fridays Review: Compounded GLP-1 Quality and Clinical Pathways

Fridays is a telehealth GLP-1 program dispensing compounded semaglutide and tirzepatide through licensed 503A pharmacies. This independent PlexusDx review compares its advertised month-to-month pricing, pharmacy standards, and support with the PlexusDx approach.

Editorial review illustration for Direct Meds — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Direct Meds Review: Evaluating Online GLP-1 Safety and Personalization

Direct Meds Review is a platform helping patients evaluate online GLP-1 providers by assessing credentials, safety standards, and personalization frameworks. Understanding these criteria supports informed decisions about compounded peptide options and provider selection.

Editorial review illustration for Brello — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Brello Review: Clinical Access Model for GLP-1 Therapy

Brello is a telehealth platform offering GLP-1 medications through a subscription model with tiered clinical assessments.

Editorial review illustration for Mochi Health and Remedy Meds — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Mochi vs Remedy Meds: Telehealth GLP-1 Access and Clinical Pathways

Mochi and Remedy Meds are telehealth platforms offering GLP-1 access through virtual consultations. Both connect patients to medications, but differ in sourcing, pricing, and clinical oversight models.

Editorial review illustration for Hims and Noom — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Noom vs Hims: Platform Design, Clinical Support, and Personalized GLP-1 Selection

Noom and Hims are two distinct telehealth platforms offering GLP-1 medication programs, each with different business models, clinical oversight structures, and personalization strategies.

Editorial review illustration for Remedy Meds — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway editorial context

Remedy Meds Pricing vs. Pharmacy Standards: What to Compare

Remedy Meds Discount positions itself as an affordable GLP-1 pathway, but cost alone doesn't determine clinical suitability or safety.